Latest News

Leptospirosis is a serious disease that dogs can get from drinking water contaminated with Leptospira bacteria. Veterinarians have discovered a technique to predict leptospirosis in dogs through the use of artificial intelligence.

New research on the experimental drug, NU-9, invented and developed by two Northwestern University scientists to treat ALS (amyotrophic lateral sclerosis), shows it is more effective than existing FDA-approved drugs for the disease.

Researchers have proposed a new statistical model for brain mapping, the goal of which is to identify brain regions associated with different traits, such as diseases, cognitive scores or behaviors.

Scientists have shown that small aggregates of various RNA binding proteins and mRNA have an important role in the regulation of neural activity.

A viral gene therapy could correct defects in a thyroid hormone "transporter", offering a potential treatment for a severe neurological disorder.

A study has shown that the drug gabapentin can promote repair and plasticity in the undamaged side of the brain after a stroke, enhancing movement recovery.

New research has found that mindfulness interventions do not lead to structural brain changes, contrary to previous findings.

Neuroscientists have pinpointed a mechanism in the brain responsible for a common type of age-related memory loss.

Scientists from Scripps Institution of Oceanography at the University of California San Diego, the University of São Paulo and UC Santa Cruz collaborated to discover and validate the enzymes responsible for the production of one of the most toxic and fast-acting neurotoxins associated with freshwater harmful algal blooms in lakes and ponds.

Researchers have developed a brain-permeable compound (25-106) that targets a signaling regulator in brain neurons. The team notes that when the new compound was administered to mice, it could alter their neurobehavior and reduce anxiety-like behavior.